Donald Trump launches TrumpRx for direct drug purchases; Pfizer cuts prices, aiming to save Americans millions annually. Photos: X.
TrumpRx: President Donald Trump announced Tuesday the launch of a new website that enables Americans to purchase prescription medications directly from the federal government, bypassing insurance intermediaries. The initiative comes alongside Trump’s announcement that Pfizer plans to lower prices on certain medications distributed in the United States, a move the president said could save Americans “hundreds of millions of dollars a year.”
“I think it’s one of the biggest things that we’ll do. We’ll be reducing drug prices by 100% in some cases, 300% or more,” Trump told reporters on the South Lawn of the White House ahead of the rollout.
Medicare Director Chris Klomp stated that the website will provide consumers with “direct access” to medications at MFN pricing, often at significantly lower rates than currently available.
“This is bypassing middlemen. It increases transparency. In many instances, prices are 80% lower than they are today,” Klomp said.
Speaking moments later in the Oval Office, Trump said, “Pfizer is committing to offer all of their prescription medications to Medicaid, and it will be at the most favored nation’s prices. It’s going to have a huge impact on bringing Medicaid costs down like nothing else.”
Most Favored Nation (MFN) prices are determined by comparing net consumer prices with those of other wealthy nations. The negotiated rate is then adjusted for the U.S. market.
Pfizer has agreed to provide some of its popular medications at discounts ranging from 50% to 100%. All new medications will be offered at the MFN rate. Among the discounted medications available through TrumpRx are:
Xeljanz for rheumatoid arthritis – 40% discount
Zavzpret for migraines – 50% discount
Eucrisa for dermatitis – 80% discount
Duavee for female osteoporosis – 85% discount
In addition to price reductions, Pfizer will invest $70 billion in bringing manufacturing facilities back to the United States and in research and development.
“It’s an historic day, because I think today we are turning the tide, and we are reversing an unfair situation,” Pfizer CEO Albert Bourla said in the Oval Office alongside Trump.
Trump criticized foreign nations for “taking advantage” of the United States on drug pricing. Health and Human Services Secretary Robert F. Kennedy Jr. highlighted the president’s hands-on role in securing the deal.
“Trump harangued and harassed us to finish the deal,” Kennedy said. “At one point, [Centers for Medicare and Medicaid Services Administrator] Dr. [Mehmet] Oz told me, ‘I can’t take the president’s calls anymore.’”
White House spokesman Kush Desai praised Trump’s approach, stating, “President Trump is doing more to lower healthcare costs than anyone else in Washington, D.C. While Democrats are threatening to shut down the federal government to subsidize health care for illegal aliens, President Trump is leveraging the power of the federal government to drastically cut drug prices for everyday Americans. Democrats talked the talk for decades about drug prices, but only President Trump is actually walking the walk.”
The drug announcement comes a day before Trump’s deadline for pharmaceutical companies to move their manufacturing operations to the U.S., or face a 100% tariff.
“Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Trump wrote on Truth Social last week.
Zubair Amin is a Senior Journalist at NewsX with over seven years of experience in reporting and editorial work. He has written for leading national and international publications, including Foreign Policy Magazine, Al Jazeera, The Economic Times, The Indian Express, The Wire, Article 14, Mongabay, News9, among others. His primary focus is on international affairs, with a strong interest in US politics and policy. He also writes on West Asia, Indian polity, and constitutional issues. Zubair tweets at zubaiyr.amin
Putin’s India Visit: Russian President Vladimir Putin received a ceremonial welcome and a Guard of…
Su-57 Vs F-35 Fighter Jet: India is weighing a crucial defence decision as it evaluates…
Russian President Vladimir Putin reached New Delhi, received a ceremonial welcome, visited Rajghat, and is…
